Strain‐Relatedness of Methicillin‐ResistantStaphylococcus aureusIsolates Recovered from Patients with Repeated Infection

This publication has 28 references indexed in Scilit:

• Phase 1/2 Double-Blind, Placebo-Controlled, Dose Escalation, Safety, and Pharmacokinetic Study of Pagibaximab (BSYX-A110), an Antistaphylococcal Monoclonal Antibody for the Prevention of Staphylococcal Bloodstream Infections, in Very-Low-Birth-Weight Neonates
  Antimicrobial Agents and Chemotherapy, 2009
• Hospitalizations and Deaths Caused by Methicillin-ResistantStaphylococcus aureus, United States, 1999–2005
  Emerging Infectious Diseases, 2007
• Carriage of Multiple Subtypes of Methicillin-ResistantStaphylococcus aureusby Intensive Care Unit Patients
  Infection Control & Hospital Epidemiology, 2006
• Environmental reservoirs of methicillin-resistant Staphylococcus aureus in isolation rooms: correlation with patient isolates and implications for hospital hygiene
  Journal of Hospital Infection, 2006
• Prevalence ofStaphylococcus aureusNasal Colonization in the United States, 2001–2002
  The Journal of Infectious Diseases, 2006
• Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX®) in hemodialysis patients
  Vaccine, 2004
• Molecular Epidemiology of Methicillin–ResistantStaphylococcus Aureusin a Veterans Administration Medical Center
  Infection Control & Hospital Epidemiology, 2002
• Use of aStaphylococcus aureusConjugate Vaccine in Patients Receiving Hemodialysis
  New England Journal of Medicine, 2002
• Nasal Carriage as a Source ofStaphylococcus aureusBacteremia
  New England Journal of Medicine, 2001
• Environmental Contamination Due to Methicillin-Resistant Staphylococcus aureus: Possible Infection Control Implications
  Infection Control & Hospital Epidemiology, 1997